Elinzanetant
id:
elinzanetant-320-11530607
title:
Elinzanetant
text:
Elinzanetant is an orally active small-molecule neurokinin/tachykinin NK1 receptor and NK3 receptor antagonist which is under development by Bayer, GlaxoSmithKline, and NeRRe Therapeutics for the treatment of hot flashes and "sex hormone disorders". It has been found to relieve hot flashes in postmenopausal women and to dose-dependently suppress luteinizing hormone, estradiol, and progesterone levels in premenopausal women. As of August 2021, elinzanetant is in phase 2 clinical trials for hot fl
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Elinzanetant
date created:
date modified:
2024-01-04T19:10:30Z
main entity:
{"identifier":"Q108453435","url":"https://www.wikidata.org/entity/Q108453435"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/87/Elinzanetant_skeletal.svg","width":203,"height":141}
fields total:
13
integrity:
15